4.7 Article

Plasma-synthesized mussel-inspired gold nanoparticles promote autophagy-dependent damage-associated molecular pattern release to potentiate immunogenic cancer cell death

Journal

JOURNAL OF INDUSTRIAL AND ENGINEERING CHEMISTRY
Volume 100, Issue -, Pages 99-111

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.jiec.2021.05.035

Keywords

Cold plasma synthesis; Gold nanoparticles; Breast carcinoma cells; Autophagy; Immunogenic cell death

Funding

  1. National Research Foundation (NRF) of Korea government (MSIT) [NRF-2016K1A4A3914113]
  2. Kwangwoon University

Ask authors/readers for more resources

This study focused on the use of polydopamine-coated gold nanoparticles (Au@PDA NPs) with excellent selectivity towards cancer cells, stimulating immunogenic cell death. The damaged cells released damage-associated molecular patterns (DAMPs) after exposure to Au@PDA NPs, regulating the subsequent immune response. Au@PDA NPs show potential for cancer immunotherapy by triggering anti-tumor immunity.
The development of an efficient tumor-specific therapeutic approach, which functions against the primary tumor and also repairs the host immune system to eradicate distant tumors, remains a clinical issue. Herein, this study focuses on the use of polydopamine-coated gold nanoparticles (Au@PDA NPs) that showed excellent selectivity towards cancer cells. The Au@PDA NPs were prepared by a plasma synthesis method with a short reaction time and minimize the use of chemicals. Prominently, Au@PDA NPs not only exhibited high cellular internalization but also stimulated immunogenic cell death (ICD) in aggressive breast carcinoma cells. Moreover, it was observed that damage-associated molecular patterns (DAMPs) were released by damaged cells together with the autophagy process after Au@PDA NPs exposure, which acted as endogenous danger signals to regulate the consequent immune response. This study highlights the novel mechanism of Au@PDA NPs-triggered anti-tumor immunity against immunosuppressive cancers, demonstrated the potential of the Au@PDA NPs for cancer immunotherapy. (c) 2021 Published by Elsevier B.V. on behalf of The Korean Society of Industrial and Engineering Chemistry.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available